Cargando…
IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288755/ http://dx.doi.org/10.1186/2051-1426-2-S3-P83 |
| _version_ | 1782352018924371968 |
|---|---|
| author | Bilyard, Hilary Mines, Charlotte Brunet, Laura Rosa Dalgleish, Angus Macintosh, Frances |
| author_facet | Bilyard, Hilary Mines, Charlotte Brunet, Laura Rosa Dalgleish, Angus Macintosh, Frances |
| author_sort | Bilyard, Hilary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288755 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887552015-01-15 IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer Bilyard, Hilary Mines, Charlotte Brunet, Laura Rosa Dalgleish, Angus Macintosh, Frances J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288755/ http://dx.doi.org/10.1186/2051-1426-2-S3-P83 Text en Copyright © 2014 Bilyard et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Bilyard, Hilary Mines, Charlotte Brunet, Laura Rosa Dalgleish, Angus Macintosh, Frances IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title | IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title_full | IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title_fullStr | IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title_full_unstemmed | IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title_short | IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| title_sort | imm-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288755/ http://dx.doi.org/10.1186/2051-1426-2-S3-P83 |
| work_keys_str_mv | AT bilyardhilary imm101animmunotherapeuticagentinclinicaldevelopmentasanadjunctivetreatmentforpancreaticcancer AT minescharlotte imm101animmunotherapeuticagentinclinicaldevelopmentasanadjunctivetreatmentforpancreaticcancer AT brunetlaurarosa imm101animmunotherapeuticagentinclinicaldevelopmentasanadjunctivetreatmentforpancreaticcancer AT dalgleishangus imm101animmunotherapeuticagentinclinicaldevelopmentasanadjunctivetreatmentforpancreaticcancer AT macintoshfrances imm101animmunotherapeuticagentinclinicaldevelopmentasanadjunctivetreatmentforpancreaticcancer |